RC-106 is a proteasome inhibitor (IC50: 35 µM) and Sigma receptor modulator with anticancer activity. RC-106 has antiproliferative activity against cancer cells including glioblastoma (GB) and multiple myeloma (MM)[1].
Molecular Weight:
355.52
CAS Number:
[1346216-50-9]
Formula:
C26H29N
Target:
Proteasome,Sigma Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted